LIP
DYN icon

Lighthouse Investment Partners’s Dyne Therapeutics DYN Stock Holding History

Lighthouse Investment Partners’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-34,000
Closed -$665K – 801
2025
Q4 		$665K Buy
34,000
+14,000
+70% +$265K 0.02% 551
2025
Q3 		$253K Buy
+20,000
New +$228K 0.01% 568

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

Lighthouse Investment Partners's DYN Position: Q1 2026 in Review

Lighthouse Investment Partners sold out of Dyne Therapeutics (DYN) in Q1 2026, closing a stake of 34,000 shares — an estimated $665K sold.

Lighthouse Investment Partners first reported a position in DYN in Q3 2025 and held it in 2 quarters. The position peaked at $665K in Q4 2025. 227 funds tracked by Wall St. Rank hold DYN as of Q1 2026.

  • Lighthouse Investment Partners reported no remaining Dyne Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Lighthouse Investment Partners sold 34,000 Dyne Therapeutics shares in Q1 2026, an estimated $665K.
  • Lighthouse Investment Partners first reported a position in Dyne Therapeutics in Q3 2025 and held it in 2 quarters.
  • Lighthouse Investment Partners's Dyne Therapeutics position peaked at $665K in Q4 2025.
  • 227 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2026.

Based on Lighthouse Investment Partners's 13F filing for Q1 2026, filed 14 May 2026.